Close
ACHEMA MIDDLE EAST 2026

Tag: Big Pharma

J&J Investment of $2B Boosts US Drug Manufacturing Capacity

Johnson & Johnson, an industry leader known for its global healthcare innovation, unveiled plans to increase its presence in the state of North Carolina...

Lupin, Sandoz Collab to Commercialise Biosimilar Ranibizumab

Lupin partners with Sandoz Group AG to commercialise and market its biosimilar ranibizumab worldwide. The product will be commercialised in a number of markets,...

Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

Anthos Therapeutics is a clinical-stage biopharmaceutical company developing abelacimab, a potential first-in-class monoclonal antibody targeting the FXI inhibition pathway Abelacimab is currently in...

Popular